Bicalutamide
SIAL/BP1115 - British Pharmacopoeia (BP) Reference Standard
Synonym: Bicalutamide (CDX); Casodex; Cosudex; N-
CAS Number: 90357-06-5
Empirical Formula (Hill Notation): C18H14F4N2O4S
Molecular Weight: 430.37
MDL Number: MFCD00869971
Linear Formula: C18H14F4N2O4S
Product Type: Chemical
API family | bicalutamide |
application(s) | pharmaceutical pharmaceutical small molecule |
form | solid |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C18H14F4N2O4S/c1-17(26 |
InChI key | LKJPYSCBVHEWIU-UHFFFAOYSA |
manufacturer/tradename | BP |
shelf life | limited shelf life, expiry date on the label |
SMILES string | CC(O)(CS(=O)(=O)c1ccc(F)c |
storage temp. | 2-8°C |
Application: | Bicalutamide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as: |
Biochem/physiol Actions: | Bicalutamide (CDX) is a non-steriodal Androgen Receptor (AR) antagonist and a pure antiandrogen. It acts via balancing histone acetylation/deacetylation and recruitment of coregulators. Bicalutamide (CDX) abolishes androgen-mediated expression. For example, MMP13 upregulation in prostate cancer, PLZF (promyelocytic leukemia zinc finger protein), and GADD45γ (growth arrest and DNA damage inducible, gamma). Bicalutamide (CDX) is inhibited by non-genomic, transcription-independent stimulation of PI3K/AKT phosphorylation by androgens. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. |
Other Notes: | Sales restrictions may apply. |
Packaging: | Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia |
Symbol | GHS08,GHS09 |
Signal word | Danger |
Hazard statements | H351 - H360FD - H410 |
Precautionary statements | P202 - P273 - P280 - P308 + P313 - P391 - P405 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |